Journal article
A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
Abstract
Two hundred and forty-two patients with acute schizophrenia were enrolled in a double-blind, comparative, dose-finding study of a novel antipsychotic, remoxipride. Remoxipride was evaluated in a low (30 to 90 mg), medium (120 to 240 mg) and a high (300 to 600 mg) dose range and compared with a haloperidol (15 to 45 mg), which was administered to a similar group of patients. The results support the antipsychotic effect of remoxipride, with …
Authors
Lapierre YD; Ancill R; Awad G; Bakish D; Beaudry P; Bloom D; Chandrasena R; Das M; Durand C; Elliott D
Journal
Journal of Psychiatry and Neuroscience, Vol. 17, No. 4, pp. 134–145
Publication Date
October 1992
ISSN
1180-4882